Serum levels of cytokines and chemokines associated with cardiovascular disease in Brazilian patients treated with statins for dyslipidemia

International Immunopharmacology

Volumn 18, Issue 1, 2014, Pages 66-70

  Pereira, Mariana M ^a   Sant'Ana Santos, Taciana P ^a   Aras, Roque ^a   Couto, Ricardo D ^a   Sousa Atta, Maria Luiza B ^a   Atta, Ajax M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Cardiovascular disease; Chemokines; Cytokines; Hypercholesterolemia; Statins

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; ATORVASTATIN; C REACTIVE PROTEIN; CHEMOKINE; CHOLESTEROL; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SIMVASTATIN; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BRAZIL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SMOKING;

CARDIOVASCULAR DISEASE; CHEMOKINES; CYTOKINES; HYPERCHOLESTEROLEMIA; STATINS;

ADULT; AGED; ATHEROSCLEROSIS; BRAZIL; CARDIOVASCULAR DISEASES; CHEMOKINE CCL2; CHEMOKINE CXCL9; CHEMOKINES; CYTOKINES; DYSLIPIDEMIAS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; SIMVASTATIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84888230238     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.11.003     Document Type: Article

References (42)

1. G.K. Hansson, A.K.L. Robertson, and C. Söderberg-Nauclér Inflammation and atherosclerosis Annu Rev Pathol Mech Dis 1 2006 297 329
2. J. Kuiper, G.H. van Puijvelde, and E.J. van Wanrooij Immunomodulation of the inflammatory response in atherosclerosis Curr Opin Lipidol 18 2007 521 526 (Pubitemid 47462204)
3. Ministério da Saúde/SVS Sistema de Informações de Mortalidade (SIM) e IBGE 2011 Indicadores e Dados Básicos Brasil
4. H.R. Girn, N.M. Orsi, and S. Homer-Vanniasinkam An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease Vasc Med 12 2007 299 309
5. E. Galkina, and K. Ley Immune and inflammatory mechanisms of atherosclerosis Annu Rev Immunol 27 2009 97 165
6. H. Ait-Oufella, S. Taleb, Z. Mallat, and A. Tedgui Cytokine network and T cell immunity in atherosclerosis Semin Immunopathol 31 2009 23 33
7. M. Romano, L. Diomede, and M. Sironi Inhibition of monocyte chemotactic protein-1 synthesis by statins Lab Invest 80 2000 1095 1100 (Pubitemid 30483228)
8. A. Rezaie-Majd, T. Maca, and R.A. Bucek Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients Arterioscler Thromb Vasc Biol 22 2002 1194 1199 (Pubitemid 34764873)
9. T. Waehre, J.K. Damås, and L. Gullestad Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease J Am Coll Cardiol 41 2003 1460 1467 (Pubitemid 36543360)
10. T. Waehre, A. Yndestad, and C. Smith Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors Circulation 109 2004 1966 1972 (Pubitemid 38544487)
11. P.M. Ridker, C.P. Cannon, D. Morrow, and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28 (Pubitemid 40075677)
12. U.N. Khot, M.B. Khot, and C.T. Bajzer Prevalence of conventional risk factors in patients with coronary heart disease JAMA 290 2003 898 904 (Pubitemid 37430461)
13. A. Kelley-Hedgepeth, D.M. Lloyd-Jones, and A. Colvin Ethnic differences in C-reactive protein concentrations Clin Chem 54 2008 1027 1037 (Pubitemid 351793410)
14. T. Shah, P. Newcombe, and L. Smeeth Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction Circ Cardiovasc Genet 3 2010 436 444
15. P. Ferroni, F. Martini, C.M. Cardarello, P.P. Gazzaniga, G. Davi, and S. Basili Enhanced interleukin-1beta in hypercholesterolemia: effects of simvastatin and low-dose aspirin Circulation 108 2003 1673 1675 (Pubitemid 37243651)
16. D. Ferro, S. Parrotto, S. Basili, C. Alessandri, and F. Violi Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia J Am Coll Cardiol 36 2000 427 431 (Pubitemid 30624003)
17. S. Zhao, Q. Li, L. Liu, Z. Xu, and J. Xiao Simvastatin reduces interleukin-1beta secretion by peripheral blood mononuclear cells in patients with essential hypertension Clin Chim Acta 344 2004 195 200 (Pubitemid 38626155)
18. S. Apostolakis, K. Vogiatzi, V. Amanatidou, and D.A. Spandidos Interleukin 8 and cardiovascular disease Cardiovasc Res 84 2009 353 360
19. A. Rezaie-Majd, T. Maca, and R.A. Bucek Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients Arterioscler Thromb Vasc Biol 22 2002 1194 1199 (Pubitemid 34764873)
20. T. Kanda, and T. Takahashi Interleukin-6 and cardiovascular diseases Jpn Heart J 45 2004 183 193 (Pubitemid 41518900)
21. H. Schuett, M. Luchtefeld, C. Grothusen, K. Grote, and B. Schieffer How much is too much? Interleukin-6 and its signalling in atherosclerosis Thromb Haemost 102 2009 215 222
22. J. Danesh, S. Kaptoge, and A.G. Mann Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review PLoS Med 5 4 2008 e78 10.1371/journal.pmed.0050078 (Pubitemid 351649259)
23. H. Nishida, T. Horio, and Y. Suzuki Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein Cytokine 53 2011 342 346
24. J. Musial, A. Undas, P. Gajewski, M. Jankowski, W. Sydor, and A. Szczeklik Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia Int J Cardiol 77 2001 247 253 (Pubitemid 32155911)
25. T. Lyngdoh, P. Vollenweider, G. Waeber, and P. Marques-Vidal Association of statins with inflammatory cytokines: a population-based Colaus study Atherosclerosis 219 2011 253 258
26. J. Panee Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes Cytokine 60 2012 1 12
27. H. Inadera, K. Egashira, M. Takemoto, Y. Ouchi, and K. Matsushima Increase in circulating levels of monocyte chemoattractant protein-1 with aging J Interferon Cytokine Res 19 1999 1179 1182 (Pubitemid 29502785)
28. R. Deo, A. Khera, and D.K. McGuire Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis J Am Coll Cardiol 44 2004 1812 1818 (Pubitemid 39424080)
29. L.S. Rallidis, E.S. Hamodraka, K. Fountoulaki, G. Moustogiannis, M.G. Zolindaki, and D.T. Kremastinos Simvastatin exerts its anti-inflammatory effect in hypercholesterolaemic patients by decreasing the serum levels of monocyte chemoattractant protein-1 Int J Cardiol 124 2008 271 272 (Pubitemid 351173361)
30. K.S. Park, K.J. Ahn, and B.J. Kim Circulating concentrations of monocyte chemoattractant protein-1 are associated with menopause status in Korean women Clin Chim Acta 403 2009 92 96
31. V. Pasceri, J.S. Cheng, J.T. Willerson, and E.T. Yeh Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 103 2001 2531 2534 (Pubitemid 32521959)
32. P. Welsh, M. Woodward, A. Rumley, and G. Lowe Associations of circulating TNF-α and IL-18 with myocardial infarction and cardiovascular risk markers: the Glasgow Myocardial Infarction Study Cytokine 47 2009 143 147
33. C. Heeschen, S. Dimmeler, and C.W. Hamm Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes Circulation 107 2003 2109 2114 (Pubitemid 36532192)
34. E. Porreca, C. Di Febbo, G. Baccante, M. Di Nisio, and F. Cuccurullo Increased transforming growth factor-beta(1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin J Am Coll Cardiol 39 2002 1752 1757 (Pubitemid 34595284)
35. D.J. Grainger, P.R. Kemp, and J.C. Metcalfe The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis Nat Med 1 1995 74 79
36. Z. Mallat, and A. Tedgui The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives Curr Opin Lipidol 13 2002 523 529 (Pubitemid 35231932)
37. A.K. Robertson, M. Rudling, X. Zhou, L. Gorelik, R.A. Flavell, and G.K. Hansson Disruption of TGF-beta signaling in T cells accelerates atherosclerosis J Clin Invest 112 2003 1342 1350 (Pubitemid 38057688)
38. D.J. Grainger TGF-beta and atherosclerosis in man Cardiovasc Res 74 2007 213 222
39. K.J. Lee, J.Y. Moon, and H.K. Choi Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance Clin Exp Immunol 161 2010 298 305
40. Y.C. Kim, K.K. Kim, and E.M. Shevach Simvastatin induces Foxp3 + T regulatory cells by modulation of transforming growth factor-beta signal transduction Immunology 130 2010 484 493
41. X. Meng, K. Zhang, and J. Li Statins induce the accumulation of regulatory T cells in atherosclerotic plaque Mol Med 18 2012 598 605
42. W.J. Kostis, J.Q. Cheng, J.M. Dobrzynski, J. Cabrera, and J.B. Kostis Meta-analysis of statin effects in women versus men J Am Coll Cardiol 59 2012 572 582